Evidence is urgently needed on whether corticosteroid therapy is appropriate for treating patients infected with the novel coronavirus (2019-nCoV) who are severely ill, pulmonary and critical-care clinicians say.

Treating doctors in Wuhan say they face a dilemma because, while steroids may reduce inflammatory lung injury, the medication may delay viral clearance.